+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Extracorporeal Membrane Oxygenation Market Report and Forecast 2023-2031

  • PDF Icon


  • 147 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797893
The global Extracorporeal Membrane Oxygenation market value was USD 230.6 million in 2022, driven by the increasing prevalence of respiratory and cardiac diseases across the globe. The market size is anticipated to grow at a CAGR of 4.80% during the forecast period of 2023-2031 to achieve a value of USD 351.7 million by 2031.

Extracorporeal Membrane Oxygenation Introduction

Extracorporeal membrane oxygenation (ECMO) is a life support technique used for critically ill patients with heart and/or lung failure. ECMO involves removing blood from the body, running it through a machine that oxygenates and removes carbon dioxide, and then returning it to the patient. The use of ECMO has become increasingly common in the management of acute respiratory distress syndrome (ARDS) and cardiac failure. It has been particularly useful during the COVID-19 pandemic for patients with severe respiratory failure.

ECMO is a complex and resource-intensive therapy that requires specialized training and equipment. The market for ECMO devices includes oxygenators, centrifugal pumps, heat exchangers, and cannulas. The demand for ECMO devices and services has increased in recent years, driven by the growing prevalence of ARDS and cardiac failure. The market is expected to continue growing as the technology improves and more healthcare providers become trained in its use.

Key trends in the ECMO market include the development of new ECMO technologies that are more efficient, less invasive, and easier to use. There is also a growing trend towards the use of mobile ECMO units that can be used in a variety of healthcare settings, including emergency departments and transport vehicles. Additionally, there is a focus on improving patient outcomes through the development of standardized protocols and the use of data analytics to identify best practices.

Extracorporeal Membrane Oxygenation Market Scenario

Extracorporeal Membrane Oxygenation (ECMO) is a life-saving medical technique used to provide respiratory and/or cardiac support to critically ill patients. It involves using an external pump and oxygenator to circulate blood outside the body, allowing the lungs and/or heart to rest and heal. ECMO is typically used for patients with severe respiratory or cardiac failure, such as those with acute respiratory distress syndrome (ARDS) or cardiogenic shock.

The global ECMO market is expected to grow significantly in the coming years, driven by factors such as the increasing prevalence of respiratory and cardiac diseases, growing demand for advanced medical technologies, and a rise in the number of ECMO procedures being performed worldwide. Moreover, advancements in technology and medical devices are expected to further boost the market growth.

However, the high cost associated with ECMO devices, limited availability of skilled professionals, and ethical concerns regarding the use of such devices in critically ill patients are some of the key factors that may hinder market growth. Nonetheless, increasing investments by governments and private organizations in the healthcare sector and rising awareness about the benefits of ECMO therapy are expected to create significant growth opportunities in the coming years.

Extracorporeal Membrane Oxygenation Market Segmentations

Market Breakup by Component

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

Market Breakup by Modality

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

Market Breakup by Patient Type

  • Neonates
  • Pediatric
  • Adult

Market Breakup by Application

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Extracorporeal Membrane Oxygenation Market

Some key trends in the extracorporeal membrane oxygenation (ECMO) market include:

  • Increasing demand for ECMO in the treatment of COVID-19 patients with respiratory failure
  • Technological advancements in ECMO systems, such as portable and miniaturized devices, that enhance patient outcomes and convenience
  • Growing use of ECMO in the treatment of cardiac and respiratory conditions, including acute respiratory distress syndrome (ARDS) and heart failure
  • Expansion of ECMO services in emerging markets due to rising healthcare investments and improving healthcare infrastructure
  • Increasing adoption of veno-arterial ECMO over veno-venous ECMO for cardiac arrest and cardiogenic shock cases
  • Rising collaborations and partnerships between ECMO device manufacturers and hospitals to improve patient care and research outcomes

Extracorporeal Membrane Oxygenation: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medtronic PLC
  • LivaNova PLC
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • Getinge AB
  • Maquet Holding
  • Medos Medizintechnik
  • Nipro Medical Corporation
  • CytoSorbents Corporation

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Extracorporeal Membrane Oxygenation Market Overview
3.1 Global Extracorporeal Membrane Oxygenation Market Historical Value (2016-2022)
3.2 Global Extracorporeal Membrane Oxygenation Market Forecast Value (2023-2031)
4 Global Extracorporeal Membrane Oxygenation Market Landscape
4.1 Global Extracorporeal Membrane Oxygenation Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Extracorporeal Membrane Oxygenation Product Landscape
4.2.1 Analysis by Component
4.2.2 Analysis by Modality
4.2.3 Analysis by Patient Type
4.2.4 Analysis by Application
5 Global Extracorporeal Membrane Oxygenation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Extracorporeal Membrane Oxygenation Market Segmentation
6.1 Global Extracorporeal Membrane Oxygenation Market by Component
6.1.1 Market Overview
6.1.2 Pumps
6.1.3 Oxygenator
6.1.4 Controllers
6.1.5 Cannula
6.1.6 Accessories
6.2 Global Extracorporeal Membrane Oxygenation Market by Modality
6.2.1 Market Overview
6.2.2 Veno-Arterial
6.2.3 Veno-Venous
6.2.4 Arterio-Venous
6.3 Global Extracorporeal Membrane Oxygenation Market by Patient Type
6.3.1 Market Overview
6.3.2 Neonates
6.3.3 Pediatric
6.3.4 Adult
6.4 Global Extracorporeal Membrane Oxygenation Market by Application
6.4.1 Market Overview
6.4.2 Respiratory
6.4.3 Cardiac
6.4.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
6.5 Global Extracorporeal Membrane Oxygenation Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Extracorporeal Membrane Oxygenation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Extracorporeal Membrane Oxygenation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Extracorporeal Membrane Oxygenation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Extracorporeal Membrane Oxygenation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Extracorporeal Membrane Oxygenation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic PLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 LivaNova PLC
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Terumo Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 MicroPort Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Getinge AB
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Maquet Holding
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Medos Medizintechnik
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nipro Medical Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 CytoSorbents Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Extracorporeal Membrane Oxygenation Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic plc
  • Livanova plc
  • Terumo Corporation
  • Microport Scientific Corporation
  • Getinge Ab
  • Maquet Holding
  • Medos Medizintechnik
  • Nipro Medical Corporation
  • Cytosorbents Corporation
  • Eurosets S.R.L



Table Information